C-type natriuretic-derived peptides as biomarkers in human disease

Biomarkers in Medicine

Volumn 4, Issue 4, 2010, Pages 631-639

  Lippert, Solvej ^a   Goetze, Jens Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ANP; atrial natriuretic peptide; B type natriuretic peptide; biomarker; BNP; C type natriuretic peptide natriuretic peptide; CNP; proCNP; radioimmunoassay

Indexed keywords

BIOLOGICAL MARKER; NATRIURETIC PEPTIDE TYPE C;

BONE GROWTH; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; GENETIC ASSOCIATION; HUMAN; IMMUNE SYSTEM; IMMUNOASSAY; KIDNEY DISEASE; NONHUMAN; OSSIFICATION; PATHOGENESIS; PEPTIDE SYNTHESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SEPSIS; SEQUENCE ALIGNMENT; UROGENITAL TRACT DISEASE;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR SEQUENCE DATA; NATRIURETIC PEPTIDE, C-TYPE; PROGNOSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77955593075     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.10.67     Document Type: Review

References (64)

1. Goetze JP: Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin. Chem. 50, 1503-1510 (2004
2. Scotland RS, Ahluwalia A, Hobbs AJ: C-type natriuretic peptide in vascular physiology and disease. Pharmacol. Ther. 105, 85-93 (2005)
3. Inoue K, Naruse K, Yamagami S et al.: Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system. Proc. Natl Acad. Sci. USA 100, 10079-10084 (2003
4. Takei Y: Structural and functional evolution of the natriuretic peptide system in vertebrates. Int. Rev. Cytol. 194, 1-66 (2000)
5. Wu C, Wu F, Pan J, Morser J, Wu Q: Furin-mediated processing of Pro-C-type natriuretic peptide. J. Biol. Chem. 278, 25847-25852 (2003)
6. Minamino N, Makino Y, Tateyama H, Kangawa K, Matsuo H: Characterization of immunoreactive human C-type natriuretic peptide in brain and heart. Biochem. Biophys. Res. Commun. 179, 535-542 (1991)
7. Anand-Srivastava MB: Natriuretic peptide receptor-C signaling and regulation. Peptides 26, 1044-1059 (2005)
8. Matsukawa N, Grzesik WJ, Takahashi N et al.: The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl Acad. Sci. USA 96, 7403-7408 (1999)
9. Suga S, Itoh H, Komatsu Y et al.: Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells - evidence for CNP as a novel autocrine/ paracrine regulator from endothelial cells. Endocrinology 133, 3038-3041 (1993)
10. Yandle TG, Richards AM, Nicholls MG et al.: Metabolic clearance rate and plasma half life of a-human atrial natriuretic peptide in man. Life Sci. 38, 1827-1833 (1986)
11. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C: Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 76, 91-96 (1993)
12. Barros NM, Campos M, Bersanetti PA et al.: Neprilysin carboxydipeptidase specificity studies and improvement in its detection with fluorescence energy transfer peptides. Biol. Chem. 388, 447-455 (2007)
13. Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168, 863-870 (1990) (Pubitemid 20164622)
14. Prickett TC, Yandle TG, Nicholls MG, Espiner EA, Richards AM: Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem. Biophys. Res. Commun. 286, 513-517 (2001)
15. Prickett TC, Kaaja RJ, Nicholls MG et al.: N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation. Clin. Sci. (Lond.) 106, 535-540 (2004)
16. Nielsen SJ, Rehfeld JF, Goetze JP: Mismeasure of C-type natriuretic peptide. Clin. Chem. 54, 225-227 (2008)
17. Nielsen SJ, Rehfeld JF, Pedersen F et al.: Measurement of pro-C-type natriuretic peptide in plasma. Clin. Chem. 51, 2173-2176 (2005)
18. Dietmann A, Lackner P, Helbok R et al.: Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar. J. 7, 253 (2008)
19. Prickett TC, Barrell GK, Wellby M et al.: Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by oestradiol in lambs and adult sheep. J. Endocrinol. 199, 481-487 (2008)
20. Nybo M, Nielsen LB, Nielsen SJ et al.: Discordant expression of pro-B-type and pro-C-type natriuretic peptide in newborn infants of mothers with Type 1 diabetes. Regul. Pept. 141, 135-139 (2007)
21. Chrisman TD, Schulz S, Potter LR, Garbers DL: Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides J. Biol. Chem. 268, 3698-3703 (1993)
22. Hosang K, Scheit KH: cDNA cloning identified a calmodulin-binding protein in bovine seminal plasma as bovine C-type natriuretic peptide. DNA Cell Biol. 13, 409-417 (1994)
23. Nielsen SJ, Gotze JP, Jensen HL, Rehfeld JF: ProCNP and CNP are expressed primarily in male genital organs. Regul. Pept. 146, 204-212 (2008)
24. Nielsen SJ, Iversen P, Rehfeld JF, Jensen HL, Goetze JP: C-type natriuretic peptide in prostate cancer. APMIS 117, 60-67 (2009)
25. Middendorff R, Davidoff MS, Behrends S et al.: Multiple roles of the messenger molecule cGMP in testicular function. Andrologia 32, 55-59 (2000)
26. Kim SZ, Kim SH, Park JK, Koh GY, Cho KW: Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. J. Urol. 159, 1741-1746 (1998)
27. Kuthe A, Reinecke M, Uckert S et al.: Expression of guanylyl cyclase B in the human corpus cavernosum penis and the possible involvement of its ligand C-type natriuretic polypeptide in the induction of penile erection. J. Urol. 169, 1918-1922 (2003)
28. Tamura N, Doolittle LK, Hammer RE et al.: Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc. Natl Acad. Sci. USA 101, 17300-17305 (2004)
29. Komatsu Y, Chusho H, Tamura N et al.: Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice. J. Bone Miner. Metab. 20, 331-336 (2002)
30. Pejchalova K, Krejci P, Wilcox WR: C-natriuretic peptide: an important regulator of cartilage. Mol. Genet. Metab. 92, 210-215 (2007)
31. Yasoda A, Ogawa Y, Suda M et al.: Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J. Biol. Chem. 273, 11695-11700 (1998)
32. Estrada K, Krawczak M, Schreiber S et al.: A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation. Hum. Mol. Genet. 18, 3516-3524 (2009)
33. Chusho H, Tamura N, Ogawa Y et al.: Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc. Natl Acad. Sci. USA 98, 4016-4021 (2001)
34. Yasoda A, Komatsu Y, Chusho H et al.: Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10, 80-86 (2004)
35. Bartels CF, Bukulmez H, Padayatti P et al.: Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet. 75, 27-34 (2004)
36. Prickett TC, Lynn AM, Barrell GK et al.: Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatr. Res. 58, 334-340 (2005)
37. Olney RC, Prickett TC, Yandle TG et al.: Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone. J. Clin. Endocrinol. Metab. 92, 4294-4298 (2007)
38. Prickett TC, Dixon B, Frampton C et al.: Plasma amino-terminal pro C-type natriuretic Peptide in the neonate: relation to gestational age and postnatal linear growth. J. Clin. Endocrinol. Metab. 93, 225-232 (2008)
39. Kelsall CJ, Chester AH, Sarathchandra P, Singer DR: Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells. Vascul. Pharmacol. 45, 368-373 (2006)
40. Wiley KE, Davenport AP: Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br. J. Pharmacol. 133, 568-574 (2001)
41. 41 Vollmar AM, Gerbes AL, Nemer M, Schulz R: Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs. Endocrinology 132, 1872-1874 (1993)
42. Palmer SC, Prickett TC, Espiner EA, Yandle TG, Richards AM: Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension 54, 612-618 (2009)
43. Kalra PR, Clague JR, Bolger AP et al.: Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 107, 571-573 (2003)
44. Pagel-Langenickel I, Buttgereit J, Bader M, Langenickel TH: Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy. J. Mol. Med. 85, 797-810 (2007)
45. Wang Y, de Waard MC, Sterner-Kock A et al.: Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur. J. Heart Fail. 9, 548-557 (2007)
46. Lisy O, Huntley BK, McCormick DJ, Kurlansky PA, Burnett JC Jr: Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J. Am. Coll. Cardiol. 52, 60-68 (2008)
47. Chen HH, Lainchbury JG, Burnett JC Jr: Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide dendroaspis natriuretic peptide. J. Am. Coll. Cardiol. 40, 1186-1191 (2002)
48. Komatsu Y, Nakao K, Suga S et al.: C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 129, 1104-1106 (1991)
49. McArdle CA, Olcese J, Schmidt C et al.: C-type natriuretic peptide (CNP) in the pituitary: is CNP an autocrine regulator of gonadotropes? Endocrinology 135, 2794-2801 (1994)
50. Herman JP, Langub MC Jr, Watson RE Jr: Localization of C-type natriuretic peptide mRNA in rat hypothalamus. Endocrinology 133, 1903-1906 (1993)
51. Cao LH, Yang XL: Natriuretic peptides and their receptors in the central nervous system. Prog. Neurobiol. 84, 234-248 (2008)
52. Ikeda K, Ikeda T, Onizuka T, Terashi H, Fukuda T: C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Crit. Care. 5, 37-40 (2001)
53. Schulz-Knappe P, Forssmann K, Herbst F et al.: Isolation and structural analysis of urodilatin, a new peptide of the cardiodilatin- (ANP)-family, extracted from human urine. Klin. Wochenschr. 66, 752-759 (1988)
54. Gunning ME, Brenner BM: Natriuretic peptides and the kidney: current concepts. Kidney Int. Suppl. 38, S127-S133 (1992)
55. Canaan-Kuhl S, Jamison RL, Myers BD, Pratt RE: Identification of B receptor for natriuretic peptide in human kidney. Endocrinology 130, 550-552 (1992)
56. Totsune K, Takahashi K, Murakami O et al.: Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure. Clin. Sci. (Lond.) 87, 319-322 (1994)
57. Obineche EN, Pathan JY, Fisher S et al.: Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis. Kidney Int. 69, 152-156 (2006)
58. Vollmar AM, Wolf R, Schulz R: Co-expression of the natriuretic peptides (ANP BNP, CNP) and their receptors in normal and acutely involuted rat thymus. J. Neuroimmunol. 57, 117-127 (1995)
59. Vollmar AM, Schulz R: Expression and differential regulation of natriuretic peptides in mouse macrophages. J. Clin. Invest. 95, 2442-2450 (1995)
60. Kubo A, Isumi Y, Ishizaka Y et al.: C-type natriuretic peptide is synthesized and secreted from leukemia cell lines, peripheral blood cells, and peritoneal macrophages. Exp. Hematol. 29, 609-615 (2001)
61. Qian JY, Haruno A, Asada Y et al.: Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ. Res. 91, 1063-1069 (2002)
62. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138-150 (2003)
63. Hama N, Itoh H, Shirakami G et al.: Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem. Biophys. Res. Commun. 198, 1177-1182 (1994)
64. Vlachopoulos C , Ioakeimidis N, Terentes-Printzios D et al.: Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of vasculogenic erectile dysfunction. Eur. Urol. 56, 552-558 (2009)